Results 201 to 210 of about 415,661 (358)

FRI0551 Use of glucocorticoid is the risk factor for inadequate response to the treatment of osteoporosis by denosumab [PDF]

, 2017
Kumi Orita, Tatsuya Koike
openalex   +1 more source

Integrative single cell RNA‐sequencing and spatial transcriptomics uncovers distinct macrophage‐fibroblast cross‐talk in human hip synovium between patients with femoroacetabular impingement and osteoarthritis

Arthritis &Rheumatology, Accepted Article.
Objectives Femoroacetabular impingement (FAI) and synovitis have been recognized as essential factors for developing osteoarthritis (OA) in the hip joints. However, little is known about altered synovial cellular compositions, their associated transcriptomic profiles, and cell‐cell interactions in FAI and hip OA.
Gulzada Kulzhanova, Alexis Klee, Mina Botros, Victoria L. Hansen, John Reuter, Eliya Tazreena Tashbib, Eloise Fadial, Benjamin F. Ricciardi, Brian Giordano, Chia‐Lung Wu   +9 more
wiley   +1 more source

Endoscopic retrograde biliary drainage plus glucocorticoids versus glucocorticoid alone for autoimmune pancreatitis with significant obstructive jaundice: study protocol for a multicenter, open-label, non-inferiority randomized controlled trial. [PDF]

Trials
Chen S, Liang Y, Chen D, Wang Y, Zhang G, Han Y, Meng K, Bu B, Zhu J, Zhai YQ, Li M.   +10 more
europepmc   +1 more source

Regulation of Alpha B-crystallin gene expression by glucocorticoids in normal and ras transformed fibroblasts

, 1996
B Scheier
openalex   +1 more source

AB0498 Optimisation of methotrexate dose induced successful reduction of glucocorticoids without impaired disease control in patients with rheumatoid arthritis [PDF]

, 2018
Shintaro Hirata, Tadakazu Kondo, K Yukawa, Tadahiro Tokunaga, Tatsuomi Kuranobu, Katsuhiro Oi, Yusuke Yoshida, Masamoto Funaki, Keisuke Oda, Takayuki Nojima, Eiji Sugiyama   +10 more
openalex   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study

Arthritis &Rheumatology, EarlyView.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, for the TULIP‐SC investigators   +12 more
wiley   +1 more source

Glucocorticoid Receptor Signaling: Multilevel Organization, Roles in Fetal Development, and Postnatal Outcomes. [PDF]

Int J Mol Sci
Potapova S, Isakov Y, Tyulkova E, Vetrovoy O.   +3 more
europepmc   +1 more source

Antiretroviral drugs differentially modulate glucocorticoid activity via the glucocorticoid receptor in vitro

, 2019
Michael Kuipa
openalex   +1 more source

A RARE CASE OF PNEUMOCEPHALUS AFTER EPIDURAL GLUCOCORTICOID INJECTION FOR CHRONIC BACK PAIN [PDF]

SAIRA SHAH, Salman Haider, FARRAH R KHAN, Moazzam Hussain, Amin Shah, Fatima Zohra, M Sulhan Anwar, IYAD AL-BUSTAMI, KIRAN ZAMAN   +8 more
openalex   +1 more source

Impact of Glucocorticoids on the Gut Microbiome with or without Anti-PD-L1 [PDF]

, 2019
Despina Tsementzi, Zachary S. Buchwald, Lihua Qiu, Mohammad K. Khan, Konstantinos T. Konstantinidis, Deborah Watkins Bruner, Juntian Lin   +6 more
openalex   +1 more source